TickerFacts.

Compare

Quanterix Corp vs Pacific Biosciences of California, Inc. vs Harvard Bioscience Inc vs 908 Devices Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearQuanterix Corp
QTRX		Pacific Biosciences of California, Inc.
PACB		Harvard Bioscience Inc
HBIO		908 Devices Inc.
MASS
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$138.90M$160.00M$86.55M$56.20M
Revenue growth (YoY)+1.1%+3.9%-8.1%+17.7%
Gross margin46.8%28.6%57.7%50.6%
Operating margin-90.4%-346.2%-56.1%-70.1%
Net margin-77.1%-341.5%-65.5%34.7%
Net income-$107.15M-$546.38M-$56.70M$19.49M
EPS (Diluted)-$2.51-$1.82-$1.28$0.54
Operating cash flow-$77.24M-$111.21M$6.73M-$23.69M
Free cash flow-$79.85M-$113.92M$5.47M-$24.64M
Cash & equivalents$29.84M$63.71M$8.61M$70.52M
Total assets$418.77M$784.08M$80.07M$190.07M
Total liabilities$123.04M$778.73M$66.34M$46.37M
Shareholders' equity$295.73M$5.35M$13.73M$143.70M
Return on year-end equity-36.2%n/m-412.8%13.6%
Shares outstanding46.74M301.96M44.72M36.32M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearQuanterix CorpPacific Biosciences of California, Inc.Harvard Bioscience Inc908 Devices Inc.
Latest$138.90M
Ended 2025-12-31		$160.00M
Ended 2025-12-31		$86.55M
Ended 2025-12-31		$56.20M
Ended 2025-12-31
1 year earlier$137.42M
Ended 2024-12-31		$154.01M
Ended 2024-12-31		$94.14M
Ended 2024-12-31		$47.75M
Ended 2024-12-31
2 years earlier$122.37M
Ended 2023-12-31		$200.52M
Ended 2023-12-31		$112.25M
Ended 2023-12-31		$50.23M
Ended 2023-12-31
3 years earlier$105.52M
Ended 2022-12-31		$128.30M
Ended 2022-12-31		$113.33M
Ended 2022-12-31		$46.85M
Ended 2022-12-31
4 years earlier$110.56M
Ended 2021-12-31		$130.51M
Ended 2021-12-31		$118.90M
Ended 2021-12-31		$42.21M
Ended 2021-12-31